GLP-1 (glucagon-like peptide-1) agonists are a type of medication used to treat type 2 diabetes and/or obesity. They mimic the effects of the naturally occurring hormone GLP-1 in the body, which stimulates the release of insulin and suppresses the release of glucagon, both of which help to lower blood sugar levels and result in weight loss.
Several GLP-1 agonists have been approved for the treatment of obesity, including liraglutide (Saxenda) and semaglutide (Wegovy). These medications are approved for use in adults with a body mass index (BMI) of 30 or greater, or in adults with a BMI of 27 or greater who also have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.
Liraglutide (Saxenda) is a daily injection that has been shown to help people with obesity lose weight by reducing appetite and increasing feelings of fullness. Semaglutide (Wegovy) is a once-weekly injection that has been shown to be even more effective than liraglutide at promoting weight loss.
Both medications are typically used in combination with diet and exercise to help people achieve and maintain a healthy weight. As with any medication, it is important to talk to a healthcare provider to determine if GLP-1 agonists are appropriate for an individual's specific needs and to discuss potential risks and benefits.
Wegovy (semaglutide) is a prescription medication is typically prescribed by a healthcare provider. To obtain Wegovy, you should schedule an appointment with Dr. Sidhu at Advanced Medical and Weight Loss Center in Alpharetta, Ga who can evaluate your medical history, assess your weight status, and determine if Wegovy is appropriate for you. If determined that Wegovy is right for you, they can provide you with a prescription, and you can obtain the medication at a pharmacy. Wegovy may not be covered by all insurance plans. Call Advanced Medical and Weight Loss Center at (770) 467-3975 and they can help determine if Wegovy may be covered under your insurance plan.